Real-World Use of Oritavancin for the Treatment of Osteomyelitis
Abstract Osteomyelitis is a difficult-to-treat disease that can require both surgical debridement and a prolonged course of antimicrobial therapy. Current standard of care for the antimicrobial treatment of osteomyelitis is fraught with multiple challenges and limitations. Patients typically require...
Main Authors: | Patrick J. Scoble, Joseph Reilly, Glenn S. Tillotson |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-06-01
|
Series: | Drugs - Real World Outcomes |
Online Access: | https://doi.org/10.1007/s40801-020-00194-8 |
Similar Items
-
Real-World Evidence for Oritavancin Use in Gram-Positive Infections
Published: (2020-07-01) -
The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Studies
by: Sandy Estrada, et al.
Published: (2020-06-01) -
Treatment of Acute Osteomyelitis with Once-Weekly Oritavancin: A Two-Year, Multicenter, Retrospective Study
by: Nicholas W. Van Hise, et al.
Published: (2020-06-01) -
Review of oritavancin for the treatment of acute bacterial skin and skin structure infections
by: Ana Alejandra García Robles, et al.
Published: (2018-03-01) -
Real-World Evidence Studies of Oritavancin Use in Gram-Positive Infections Augment Randomized Controlled Trials to Address Clinical and Economic Outcomes
by: Mark Redell
Published: (2020-06-01)